Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazunari Maeda

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Anticancer Research|December 27, 2011
Impact of chemotherapy for colorectal cancer on regulatory T-cells and tumor immunityKazunari Maeda, Shoichi Hazama, Kazuhisa Tokuno, et al.
JAMA Network Open|May 15, 2026
Early-Phase Oral Antiviral Use and Post-COVID-19 Condition in OutpatientsMakoto Hibino, Ayumi Shintani, Hiroyuki Murayama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2011
[Investigation of epiphora following S-1 therapy]Hirotaka Kitamura, Tamon Miyanaga, Hisatou Shin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 25, 2022
Safety and Immunogenicity of mRNA Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Lung Cancer Receiving Immune Checkpoint Inhibitors: A Multicenter Observational Study in JapanMakoto Hibino, Kiyoaki Uryu, Takayuki Takeda, et al.
Anticancer Research|July 31, 2014
Predictive biomarkers for the outcome of vaccination of five therapeutic epitope peptides for colorectal cancerShoichi Hazama, Hiroko Takenouchi, Ryouichi Tsunedomi, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Anticancer Research|December 27, 2011
Impact of chemotherapy for colorectal cancer on regulatory T-cells and tumor immunityKazunari Maeda, Shoichi Hazama, Kazuhisa Tokuno, et al.
JAMA Network Open|May 15, 2026
Early-Phase Oral Antiviral Use and Post-COVID-19 Condition in OutpatientsMakoto Hibino, Ayumi Shintani, Hiroyuki Murayama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2011
[Investigation of epiphora following S-1 therapy]Hirotaka Kitamura, Tamon Miyanaga, Hisatou Shin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 25, 2022
Safety and Immunogenicity of mRNA Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Lung Cancer Receiving Immune Checkpoint Inhibitors: A Multicenter Observational Study in JapanMakoto Hibino, Kiyoaki Uryu, Takayuki Takeda, et al.
Anticancer Research|July 31, 2014
Predictive biomarkers for the outcome of vaccination of five therapeutic epitope peptides for colorectal cancerShoichi Hazama, Hiroko Takenouchi, Ryouichi Tsunedomi, et al.
Pageof 3